[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$apvos Graphic](https://lunarcrush.com/gi/w:26/t:$apvos.png) $apvos

APVO's APVO436 shows promising safety data in AML treatment, with no CRS events reported. The community is shrinking, with a decrease in engagements and mentions.

### About $apvos
APVO is a ticker symbol, likely representing a company or project in the biotechnology or pharmaceutical industry.  

### Engagements: XX [#](/topic/$apvos/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$apvos/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$apvos/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Month**: XXX -XX%  
**1-Year High**: XXXXX on 2025-06-18  
**1-Year Low**: X on 2025-06-26  

| Social Network | X |
| -------------- | - |
| Engagements    | X |
  

  
  
### Mentions: X [#](/topic/$apvos/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$apvos/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$apvos/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Month**: X -XX%  
**1-Year High**: X on 2025-06-18  
**1-Year Low**: X on 2025-06-17  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$apvos/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$apvos/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$apvos/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $apvos in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1 Month**: X -XX%  
**1-Year High**: X on 2025-06-18  
**1-Year Low**: X on 2025-06-17  

**Top topics mentioned**
In the posts about $apvos in the last XX hours

[positions](/topic/positions), [redchip](/topic/redchip)

### Top Social Posts [#](/topic/$apvos/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"🛡 Safety Sets $APVO's APVO436 Apart in AML Treatment Safety is a critical differentiator for immunotherapies. Remarkably $APVO's data show that none of the patients treated with APVO436 experienced cytokine release syndrome (CRS) a common and serious side effect of T-cell engaging therapies. This clean safety profile stems from APVO436s carefully engineered design and positions it as a well-tolerated AML treatment. Why It Matters: No CRS events: In the RAINIER trial to date no patients have experienced CRS when treated with APVO436 plus standard therapy a highly unusual outcome for a"  
[@RedChip](/creator/x/RedChip) on [X](/post/tweet/1947630251535663438) 2025-07-22 12:10:11 UTC 5588 followers, XXX engagements